318 results
Page 3 of 16
10-Q
4f57 bdhc1l3
3 May 18
Quarterly report
4:08pm
DEF 14A
vv02h94v hsrs70ha2em
25 Apr 18
Definitive proxy
12:00am
10-K
EX-10.51
3deu spb7
12 Feb 18
Annual report
12:00am
10-K
EX-10.20
ng1 kznayk
12 Feb 18
Annual report
12:00am
10-K
EX-10.44
39w6i2ecj
12 Feb 18
Annual report
12:00am
10-K
EX-10.30
cscjvx5
12 Feb 18
Annual report
12:00am
10-K
b5upreoqqv
12 Feb 18
Annual report
12:00am
10-K
EX-10.32
bga2300sn5xt92
12 Feb 18
Annual report
12:00am
6-K
EX-99.1
sccd21cty hra
27 Dec 17
Teva Announces Exclusive Launch of a Generic Version of Reyataz® in the United States
12:00am
6-K
EX-99.1
bcief2f sdn3v
18 Aug 17
Teva Announces Exclusive Launch of Generic Axiron® In the United States
12:00am
6-K
EX-99.1
0r64suo
24 Jul 17
Live Filing
12:00am
6-K
EX-99.1
9xegr yn9ceuksedk3y
7 Jun 17
Live Filing
12:00am
6-K
EX-99.1
0z3f4tlmly865vmnpz
26 Oct 16
Collaboration Features First Integration of The Weather Company data with IBM Watson Health Cloud
12:00am
6-K
EX-99.1
dwn7b0d
6 Oct 16
Teva and Celltrion Announce Exclusive Biosimilar Commercial Partnership
12:00am
6-K
EX-99.1
s21dn 1uo70
20 Sep 16
Teva and Regeneron Announce Global Collaboration to Develop and Commercialize Fasinumab, an Investigational NGF Antibody for Chronic Pain
12:00am
6-K
EX-99.1
o1vsf76c9pgtd8elb
18 Aug 16
First Intravenous Anti-IL-5 Biologic Therapy for Severe Eosinophilic Asthma Now Approved in Europe
12:00am
424B5
50mqm04v5e
18 Jul 16
Prospectus supplement for primary offering
12:00am
6-K
d0q6d4o5lo kw
13 Jul 16
Current report (foreign)
12:00am